日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FOXJ1 mediates taxane resistance through regulation of microtubule dynamics.

FOXJ1 通过调节微管动力学介导紫杉烷类药物耐药性。

Xie Fang, Gjyrezi Ada, Fein Daniel, Labaf Maryam, Poluben Larysa, Ersoy-Fazlioglu Betul, Dennehy Christopher M, Voznesensky Olga, Gad Aniket, Corey Eva, Varkaris Andreas, Einstein David J, Bhatt Rupal S, Giannakakou Paraskevi, Balk Steven P

Targeting Wnt/β-catenin and circadian regulator restores PRC2/EZH2-controlled chromatin bivalency and suppresses cell state diversity

靶向Wnt/β-catenin和昼夜节律调节因子可恢复PRC2/EZH2控制的染色质二价性并抑制细胞状态多样性

Yang, Yatian; Zhang, Xiong; Venkadakrishnan, Varadha Balaji; Zou, Hongye; Zheng, Xingling; Guo, Shiyao; Chen, Christopher Z; Borowsky, Alexander D; Corey, Eva; Evans, Ronald M; Gao, Allen C; Dall'Era, Marc A; Zoubeidi, Amina; Lara, Primo N; Kung, Hsing-Jien; Chen, Xinbin; Beltran, Himisha; Chen, Hong-Wu

Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer

在同源重组功能正常的的前列腺癌中,AR靶向疗法与PARP抑制剂之间缺乏协同作用

Traphagen, Nicole A; Wheeler, Esmé; Li, Rong; Akhshi, Tara; Ravindranathan, Ramya; Alfieri, Christian; Lu, Feng; Ahmed, Buraq; Tewari, Alok K; Balk, Steven P; Nelson, Peter S; Corey, Eva; Long, Henry; D'Andrea, Alan D; Qiu, Xintao; Brown, Myles

Global mRNA 3'UTR lengthening in small-cell neuroendocrine carcinoma

小细胞神经内分泌癌中mRNA 3'UTR的整体延长

Zhang, Yi; Zhao, Xiaofan; Wang, Huan; Hu, Ya-Mei; Sun, Xiao-Xin; Zhao, Faming; Du, Shunyu; Dai, Roselyn S; Andeen, Nicole K; Sears, Rosalie C; Corey, Eva; Brody, Jonathan R; Alumkal, Joshi J; Mills, Gordon B; Nelson, Peter S; Dai, Mu-Shui; Xia, Zheng

BPTF regulates androgen receptor activity by enhancing chromatin accessibility and stabilizing the AR-FOXA1 interaction

BPTF通过增强染色质可及性和稳定AR-FOXA1相互作用来调节雄激素受体活性。

Jeon, Hee-Young; Khadka, Sudeep; Pornour, Majid; Ryu, Hyunju; Chen, Hegang; Hussain, Arif; Lam, Hung-Ming; Corey, Eva; Oo, Htoo Zarni; Gleave, Martin; Che, Xiaofang; Barbieri, Christopher; Qi, Jianfei

BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress.

靶向 BCL-XL 的 BH3 模拟物对 RB1 缺失和复制压力的实体瘤有效

Varkaris Andreas, Wang Keshan, Nouri Mannan, Kozlova Nina, Schmidt Daniel R, Stavridi Anastasia, Arai Seiji, Ambrosio Nicholas, Poluben Larysa, Jimenez-Vacas Juan M, Westaby Daniel, Carmichael Juliet, Xie Fang, Figueiredo Ines, Buroni Lorenzo, Neeb Antje, Gurel Bora, Chevalier Nicholas, Brown Lisha, Voznesensky Olga, Chen Shao-Yong, Russo Joshua W, Yuan Xin, Juric Dejan, Beltran Himisha, De Bono Johann S, Vander Heiden Matthew G, Einstein David J, Muranen Taru, Corey Eva, Sharp Adam, Balk Steven P

Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors.

BRD4抑制剂可有效靶向治疗神经内分泌前列腺癌的肿瘤谱系可塑性

Zhang Xiong, Yang Yatian, Zou Hongye, Yang Yang, Zheng Xingling, Corey Eva, Zoubeidi Amina, Mitsiades Nicolas, Yu Ai-Ming, Li Yuanpei, Chen Hong-Wu

BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancer

BET抑制剂可抑制胃肠道基因特征阳性去势抵抗性前列腺癌临床前模型中的肿瘤生长

Shukla, Shipra; Li, Dan; Cho, Woo Hyun; Schoeps, Dana M; Nguyen, Holly M; Conner, Jennifer L; Roskes, Marjorie L; Tehim, Anisha; Bayshtok, Gabriella; Pachai, Mohini R; Yan, Juan; Teri, Nicholas A; Campeau, Eric; Attwell, Sarah; Trojer, Patrick; Ostrovnaya, Irina; Gopalan, Anuradha; Khurana, Ekta; Corey, Eva; Chi, Ping; Chen, Yu

Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer

致命性前列腺癌的肿瘤内和肿瘤间表型异质性模式

Roudier, Martine P; Gulati, Roman; Sayar, Erolcan; Patel, Radhika A; Tratt, Micah; Richards, Helen M; Cejas, Paloma; Munoz Gomez, Miguel; Qiu, Xintao; Xie, Yingtian; Hanratty, Brian; Zaidi, Samir; Zhao, Jimmy L; Adil, Mohamed; Mittal, Chitvan; Zhao, Yibai; Dumpit, Ruth; Coleman, Ilsa; Low, Jin-Yih; Persse, Thomas; Galipeau, Patricia; Lee, John K; Tretiakova, Maria; Chambers, Meagan; Vakar-Lopez, Funda; True, Lawrence D; Perrone, Marie; Lam, Hung-Ming; Kollath, Lori A; Ding, Chien-Kuang Cornelia; Harmon, Stephanie; Cheng, Heather H; Yu, Evan Y; Montgomery, Robert B; Hawley, Jessica E; Lin, Daniel W; Corey, Eva; Schweizer, Michael T; Setty, Manu; Ha, Gavin; Sawyers, Charles L; Morrissey, Colm; Long, Henry; Nelson, Peter S; Haffner, Michael C

PROX1 is an early driver of lineage plasticity in prostate cancer.

PROX1 是前列腺癌谱系可塑性的早期驱动因素

Duan Zhi, Shi Mingchen, Kumaraswamy Anbarasu, Lin Dong, Khokhani Dhruv, Wang Yong, Zhang Chao, Flores Diana, Rodansky Eva, Swaim Olivia A, Storck William K, Beck Hannah N, Patel Radhika A, Sayar Erolcan, Hanratty Brian P, Xue Hui, Dong Xin, Maylin Zoe R, Wan Rensheng, Quigley David A, Sjöström Martin, Hu Ya-Mei, Zhao Faming, Xia Zheng, Cheng Siyuan, Yu Xiuping, Feng Felix Y, Zhang Li, Aggarwal Rahul, Small Eric J, Ravikumar Visweswaran, Rao Arvind, Bedi Karan, Lee John K, Morrissey Colm, Coleman Ilsa, Nelson Peter S, Corey Eva, Udager Aaron M, Rebernick Ryan J, Cieslik Marcin P, Chinnaiyan Arul M, Yates Joel A, Haffner Michael C, Wang Yuzhuo, Alumkal Joshi J